Miika Ahdesmäki - Concepedia

Author

Miika Ahdesmäki

Also Known As

Jerome T. Mettetal, M. Ahdesmaki, Miika Ahdesmaki, Miika Ahdesmki, Miika Ahdesmäki, Miika J Ahdesmäki, Miika J. Ahdesmaki, Miika J. Ahdesmäki

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (United States)AstraZeneca (Singapore)Institute for Systems Biology

About

Miika Ahdesmäki is an author at AstraZeneca (United Kingdom) specializing in medicine, cancer research, and tumor heterogeneity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.7K
2	Engineering	3	3	1.1K
3	Public Health	2	2	97
4	Health Sciences	1	1	407
5	Natural Sciences	1	1	16

Miika Ahdesmäki

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research Zhongwu Lai, Aleksandra Markovets, Miika Ahdesmäki, Nucleic Acids Research EngineeringGeneticsPathologyGenomicsHigh Throughput Sequencing	2016	1K
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson, Cancer Immunology Research ImmunologyImmunoeditingImmunotherapeutic Drug DiscoveryImmunotherapeuticsImmunotherapy	2016	407
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models Catherine A. Eberlein, Daniel Stetson, Aleksandra Markovets, Cancer Research	2015	293
Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue Richard D. Kennedy, Max Bylesjö, Peter Kerr, Journal of Clinical Oncology	2011	187
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao, Molecular Cancer Therapeutics Azd5153 ExposurePathologyPharmacotherapyTumor BiologyMyeloid Neoplasia	2016	147
Robust detection of periodic time series measured from biological systems Miika Ahdesmäki, Harri Lähdesmäki, Ron Pearson, BMC Bioinformatics	2005	130
Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer Anna Gogleva, Dimitris Polychronopoulos, Matthias Pfeifer, Nature Communications	2022	88
PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer Austin N. Kirschner, Jie Wang, Riet van der Meer, JNCI Journal of the National Cancer Institute	2014	86
Disambiguate: An open-source application for disambiguating two species in next generation sequencing data from grafted samples Miika Ahdesmäki, Simon R. Gray, Justin Johnson, F1000Research GeneticsGenomicsBioinformatics DatabaseHigh Throughput SequencingDna Barcoding	2016	81
The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle Kenneth A. Dyar, Stefano Ciciliot, Guidantonio Malagoli Tagliazucchi, Molecular Metabolism	2015	77

Page 1